GlobeNewswire: Merit Medical Systems, Inc.
- Merit Medical’s Embosphere® Microspheres Receive FDA 513(f)(2) (de novo) Classification for Prostatic Artery Embolization Indication June 22, 2017
- Merit Medical Announces Appointment of New Director May 26, 2017
- Merit Medical to Participate at Three Conferences May 3, 2017
- Merit Medical Reports Results for First Quarter of 2017 April 27, 2017
- Merit Medical Systems to Announce First Quarter Results on April 27, 2017 April 4, 2017
- Merit Medical to Participate at Needham Healthcare Conference March 30, 2017
- Merit Medical Announces Closing of Public Offering of Common Stock March 29, 2017
- Merit Medical Announces Full Exercise of Option to Purchase Additional Common Stock March 27, 2017
- Merit Medical Announces Pricing of Public Offering of Common Stock March 22, 2017
- Merit Medical Announces Commencement of Public Offering of Common Stock March 20, 2017